PYPD
6.60+0.29 +4.60%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- PYPD
- Exchange
- NCM
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $134.06M
- Employees
- 69
- Currency
- USD
- Website
- https://www.polypid.com
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also…
Latest coverage
- PolyPid: 3 Key Takeaways for Long-Term Investors
November 11, 2026